← FDA DRUG APPROVALS

FDA ANDA · ANDA075831

BISOPROLOL FUMARATE

Sponsor: NATCO PHARMA USA

APPLICATION
ANDA075831
TYPE
ANDA
ORIGINAL APPROVAL
2005-12-14
LATEST ACTION
2015-06-29
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

BISOPROLOL FUMARATEDiscontinued
BISOPROLOL FUMARATE 10MG · TABLET · ORAL
BISOPROLOL FUMARATEDiscontinued
BISOPROLOL FUMARATE 5MG · TABLET · ORAL

Approval history

2015-06-29Labeling · Supplement 10 · standardAP
2008-06-27Labeling · Supplement 4AP
2005-12-14OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →